Carotid Stenosis

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Elutia
ElutiaSILVER SPRING, MD
1 program
CorMatrix ECM for Carotid RepairN/A1 trial
Active Trials
NCT01569594CompletedEst. Dec 2016
Contego Medical
Contego MedicalNC - Raleigh
1 program
Neuroguard IEP Direct SystemN/A1 trial
Active Trials
NCT05845710CompletedEst. Aug 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Contego MedicalNeuroguard IEP Direct System
ElutiaCorMatrix ECM for Carotid Repair

Clinical Trials (2)

NCT05845710Contego MedicalNeuroguard IEP Direct System

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Start: Oct 2023Est. completion: Aug 2025
N/ACompleted
NCT01569594ElutiaCorMatrix ECM for Carotid Repair

CorMatrix ECM for Carotid Repair Following Endarterectomy Registry

Start: Apr 2012Est. completion: Dec 2016
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space